These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26657972)

  • 1. DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck.
    King AD; Chow SK; Yu KH; Mo FK; Yeung DK; Yuan J; Law BK; Bhatia KS; Vlantis AC; Ahuja AT
    PLoS One; 2015; 10(12):e0144770. PubMed ID: 26657972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma.
    Meyer HJ; Leifels L; Schob S; Garnov N; Surov A
    Magn Reson Imaging; 2018 Jan; 45():72-77. PubMed ID: 28963049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck.
    Chawla S; Kim S; Dougherty L; Wang S; Loevner LA; Quon H; Poptani H
    AJR Am J Roentgenol; 2013 Jan; 200(1):35-43. PubMed ID: 23255739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations Between Histogram Analysis DCE MRI Parameters and Complex
    Surov A; Leifels L; Meyer HJ; Winter K; Sabri O; Purz S
    Anticancer Res; 2018 Mar; 38(3):1637-1642. PubMed ID: 29491096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced MRI for advanced esophageal cancer response assessment after concurrent chemoradiotherapy.
    Sun NN; Liu C; Ge XL; Wang J
    Diagn Interv Radiol; 2018 Jul; 24(4):195-202. PubMed ID: 30091709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.
    Kim SY; Kim JS; Yi JS; Lee JH; Choi SH; Nam SY; Cho KJ; Lee SW; Kim SB; Roh JL
    Ann Surg Oncol; 2011 Sep; 18(9):2579-84. PubMed ID: 21409485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An exploratory study into the role of dynamic contrast-enhanced (DCE) MRI metrics as predictors of response in head and neck cancers.
    Agrawal S; Awasthi R; Singh A; Haris M; Gupta RK; Rathore RK
    Clin Radiol; 2012 Sep; 67(9):e1-5. PubMed ID: 22583950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitations.
    King AD; Thoeny HC
    Cancer Imaging; 2016 Aug; 16(1):23. PubMed ID: 27542718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
    Ng SH; Lin CY; Chan SC; Lin YC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Chang CJ; Wang JJ
    PLoS One; 2014; 9(12):e115933. PubMed ID: 25531391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeatability of arterial input functions and kinetic parameters in muscle obtained by dynamic contrast enhanced MR imaging of the head and neck.
    Koopman T; Martens RM; Lavini C; Yaqub M; Castelijns JA; Boellaard R; Marcus JT
    Magn Reson Imaging; 2020 May; 68():1-8. PubMed ID: 31978517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases.
    Shukla-Dave A; Lee NY; Jansen JF; Thaler HT; Stambuk HE; Fury MG; Patel SG; Moreira AL; Sherman E; Karimi S; Wang Y; Kraus D; Shah JP; Pfister DG; Koutcher JA
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1837-44. PubMed ID: 21601373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic analysis of DCE-MRI data of locally advanced cervical carcinoma with the Brix model.
    Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
    Acta Oncol; 2019 Jun; 58(6):828-837. PubMed ID: 30810443
    [No Abstract]   [Full Text] [Related]  

  • 13. Application of Dynamic Contrast-Enhanced MRI Parameters for Differentiating Squamous Cell Carcinoma and Malignant Lymphoma of the Oropharynx.
    Park M; Kim J; Choi YS; Lee SK; Koh YW; Kim SH; Choi EC
    AJR Am J Roentgenol; 2016 Feb; 206(2):401-7. PubMed ID: 26797371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast enhancement magnetic resonance imaging (DCE-MRI) for differential diagnosis in head and neck cancers.
    Lee FK; King AD; Ma BB; Yeung DK
    Eur J Radiol; 2012 Apr; 81(4):784-8. PubMed ID: 21376492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of diffusion weighted and dynamic contrast-enhanced MRI in loco-regionally advanced head and neck cancer treated with concomitant chemoradiotherapy.
    Garbajs M; Strojan P; Surlan-Popovic K
    Radiol Oncol; 2019 Mar; 53(1):39-48. PubMed ID: 30840595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative dynamic contrast-enhanced MR imaging can be used to predict the pathologic stages of oral tongue squamous cell carcinoma.
    Guo N; Zeng W; Deng H; Hu H; Cheng Z; Yang Z; Jiang S; Duan X; Shen J
    BMC Med Imaging; 2020 Oct; 20(1):117. PubMed ID: 33066760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvessel barrier dysfunction in sinonasal inverted papilloma-associated squamous cell carcinoma and its manifestation in dynamic contrast-enhanced MRI.
    Xian M; Yu J; Li Z; Piao Y; Wang C; Xian J; Zhang L
    Int Forum Allergy Rhinol; 2024 Jul; 14(7):1173-1181. PubMed ID: 38247185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
    Kim Y; Kim SH; Song BJ; Kang BJ; Yim KI; Lee A; Nam Y
    Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-tumour histogram analysis of pharmacokinetic parameters from dynamic contrast-enhanced MRI in resectable oesophageal squamous cell carcinoma can predict T-stage and regional lymph node metastasis.
    Chen YL; Li R; Chen TW; Ou J; Zhang XM; Chen F; Wu L; Jiang Y; Laws M; Shah K; Joseph B; Hu J
    Eur J Radiol; 2019 Mar; 112():112-120. PubMed ID: 30777199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
    Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
    Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.